SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-002162
Filing Date
2022-02-28
Accepted
2022-02-28 07:00:40
Documents
14
Period of Report
2022-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K beam-20220228.htm   iXBRL 8-K 62013
2 EX-99.1 beam-ex99_1.htm EX-99.1 197501
3 GRAPHIC img55885398_0.jpg GRAPHIC 12215
  Complete submission text file 0000950170-22-002162.txt   409957

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20220228_pre.xml EX-101.PRE 10607
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20220228.xsd EX-101.SCH 2474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20220228_lab.xml EX-101.LAB 17187
8 EXTRACTED XBRL INSTANCE DOCUMENT beam-20220228_htm.xml XML 4520
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39208 | Film No.: 22683873
SIC: 2836 Biological Products, (No Diagnostic Substances)